- Home
- / Kalytera Therapeutics
Kalytera Therapeutics
Stock Price
$0
2021-06-08
Market Capitalization
$25.7 M
2021-06-08
Kalytera Therapeutics Summary
Company Summary
- Overview
- Kalytera Therapeutics is a pharmaceutical company developing a class of proprietary cannabidiol therapeutics. It is mainly focused on graft versus host disease (GVHD).
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- San Rafael, CA, US | view all locations
- Website
- https://claritaspharma.com/
- Cybersecurity rating
Table of Contents
Key People
Robin Hutchison, Director
Robert Farrell, President and CEO, Director
LocationsView all
1 location detected
San Rafael, CA HQ
United States
4040 Civic Center Dr #200